Bronchodilation from intravenous theophylline in patients with cystic fibrosis: results of a blinded placebo‐controlled crossover clinical trial
Authors:
- Daniel M. CanafaxDCDaniel M. Canafax
- Robert J. CipolleRCRobert J. Cipolle
- Donald L. UdenDUDonald L. Uden
- Chap T. LeCLChap T. Le
- Warren J. WarwickWWWarren J. Warwick
- 1 January 1989
- journal article
- clinical trial
- Published by Wiley in Pediatric Pulmonology
- Vol. 6 (3) , 172-179
Abstract
Most patients with cystic fibrosis (CF) eventually develop chronic obstructive pulmonary disease and theoretically could benefit from theophylline therapy. The purpose of this study was to investigate the pharmacologic response to intravenous theophylline by pulmonary function tests (PFT) and the theophylline pharmacokinetics in patients with CF. A randomized, double‐blind, placebo‐controlled, crossover trial was conducted in 10 ambulant patients with CF (5 females, 5 males), aged 11 to 21 years. Each patient received an intravenous dose of theophylline and normal saline over 1/2 hour on consecutive days. Spirometry and whole‐body plethysmography were performed at baseline, 1, 3, 5, and 7 h after the theophylline dose, and 10 blood samples were collected over 9 h on both study days. The percent change of PFT from the baseline was recorded. Analysis of variance for balanced two‐period crossover design was used to evaluate the effectiveness of theophylline therapy. The serum concentration (Conc.) vs. time data were fitted using nonlinear least‐squares regression analysis. The theophylline dose administered was 7.9 ± 0.4 (mean ± SD) mg/kg, which produced a maximal Conc. (Cmax) of 14.6 ± 2.7 m̈g/ml. The half‐life (T1/2), volume of distribution (Vd), and total body clearance (TBC) were 4.9 ± 1.9h, 537 ± 124 mL/kg, and 80 ± 16 ml/h/kg, respectively. The results of PFT data analysis indicated that maximal improvement in PFT was observed at 5 h, and statistically significant improvements occurred in forced expiratory flow during the first .75 s (FEV.75), FEV1.0, FEV1.0/vital capacity (VC), FEF when 50% and when 75% of VC is expired, and FEF between 25% and 75% of VC (P <0.05). These results suggest that in CF patients, theophylline can produce a delayed but significant improvement in PFT.Keywords
This publication has 26 references indexed in Scilit:
- Mechanism of action of methylxanthines in asthmaJournal of Allergy and Clinical Immunology, 1988
- Prospective controlled study of home and hospital therapy of cystic fibrosis pulmonary diseaseThe Journal of Pediatrics, 1987
- Clinical features, survival rate, and prognostic factors in young adults with cystic fibrosisThe American Journal of Medicine, 1987
- Effects of postural drainage, incorporating the forced expiration technique, on pulmonary function in cystic fibrosisRespiratory Medicine, 1986
- On the Mechanism of Action of Theophylline and CaffeineActa Medica Scandinavica, 1985
- Cystic fibrosisPostgraduate Medical Journal, 1984
- PROGNOSIS FOR SURVIVAL WITH CYSTIC FIBROSIS: THE EFFECTS OF EARLY DIAGNOSIS AND CYSTIC FIBROSIS CENTER CAREActa Paediatrica, 1982
- Introduction to sample size determination and power analysis for clinical trialsControlled Clinical Trials, 1981
- Evaluation of the forced expiration technique as an adjunct to postural drainage in treatment of cystic fibrosis.BMJ, 1979
- A new prognostic score and clinical evaluation system for cystic fibrosisThe Journal of Pediatrics, 1973